| Literature DB >> 28788042 |
Navina Nallamuthu1, Michael Braden2, John Oxford3, David Williams4, Mangala Patel5.
Abstract
To formulate an alginate dental impression material with virucidal properties, experimental alginate dental impression materials were developed and the formulations adjusted in order to study the effect on pH profiles during setting. Commercially available materials served as a comparison. Eight experimental materials were tested for antiviral activity against Herpes Simplex Virus type 1 (HSV-1). Changing the amount of magnesium oxide (MgO) used in the experimental formulations had a marked effect on pH. Increasing MgO concentration corresponded with increased pH values. All experimental materials brought about viral log reductions ranging between 0.5 and 4.0 over a period of 4 h. The material with the lowest pH was the most effective. The current work highlights the very important role of MgO in controlling pH profiles. This knowledge has been applied to the formulation of experimental alginates; where materials with pH values of approximately 4.2-4.4 are able to achieve a significant log reduction when assayed against HSV-1.Entities:
Keywords: Herpes Simplex Virus type 1; alginate; antiviral; magnesium oxide; pH
Year: 2015 PMID: 28788042 PMCID: PMC5507020 DOI: 10.3390/ma8041966
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1pH changes of Neocolloid, Empress and experimental alginates with varying MgO concentrations (0%–10%).
Figure 2Log reduction/−log10TCID50 of HSV-1 with experimental alginate materials with varying MgO concentrations (0%–10%).
Composition of experimental materials and source of constituents (ExII contains 10% MgO and ExII F1 contains no MgO).
| Component | Supplier | ExII (%w/w) | ExII F1 (%w/w) |
|---|---|---|---|
| Manugel®DJX | ISP Alginates Ltd., Kent, UK | 14.00 | 14.00 |
| Crystacast plaster | CFS Partnership, Cornwall, UK | 9.00 | 9.00 |
| Potassium fluorotitanate | Rose Chemicals Ltd., London, UK | 3.00 | 3.00 |
| Tetrasodium pyrophosphate | Sigma-Aldrich Co. Ltd., Dorset, UK | 0.84 | 0.84 |
| Diatomaceous earth | Sigma-Aldrich Co. Ltd., Dorset, UK | 63.16 | 73.16 |
| Magnesium oxide | Sigma-Aldrich Co. Ltd., Dorset, UK | 10.00 | – |
Composition of experimental alginates with varying magnesium oxide (MgO) content for virology study (ExII contains 10% MgO and ExII F1 contains no MgO).
| Component | Formulation | ||||||
|---|---|---|---|---|---|---|---|
| ExII F1 | ExII F2 | ExII F3 | ExII F4 | ExII F5 | ExII F6 | ExII F7 | |
| %w/w | |||||||
| Manugel®DJX | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.0 |
| Crystacast plaster | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 |
| Potassium fluorotitanate | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Tetrasodium pyrophosphate | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 |
| Diatomaceous earth | 73.16 | 73.06 | 72.16 | 71.91 | 71.76 | 71.56 | 71.16 |
| Magnesium oxide | 0 | 0.10 | 1.00 | 1.25 | 1.40 | 1.60 | 2.00 |